Contact

Payer

Pharma

Provider

Formulary guidance and transparency from P&T to point of care

MMIT Reality Check on Viscosupplements (Apr 2018)

Posted by Matt Breese on Apr 20, 2018

According to our recent payer coverage analysis for viscosupplements, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Read More

Topics: Specialty, Market Access, Branding & Marketing

MMIT Reality Check on Hepatitis C (Apr 2018)

Posted by Matt Breese on Apr 12, 2018

According to our recent payer coverage analysis for Hepatitis C treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Read More

Topics: Specialty, Market Access, Branding & Marketing

MMIT Reality Check on Detoxification Agents (Apr 2018)

Posted by Matt Breese on Apr 6, 2018

According to our recent payer coverage analysis for detoxification agents, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Read More

Topics: Specialty, Market Access, Branding & Marketing

MMIT Reality Check on Antipsychotics (Mar 2018)

Posted by Matt Breese on Mar 29, 2018

According to our recent payer coverage analysis for atypical antipsychotic treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Read More

Topics: Specialty, Market Access, Branding & Marketing

MMIT Reality Check on Narcotic Pain (Mar 2018)

Posted by Matt Breese on Mar 20, 2018

According to our recent payer coverage analysis for narcotic pain treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Read More

Topics: Specialty, Market Access, Branding & Marketing

MMIT Reality Check on Immunology: Rheumatoid Arthritis (Mar 2018)

Posted by Matt Breese on Mar 18, 2018

According to our recent payer coverage analysis for rheumatoid arthritis treatments, combined with news from key healthcare influencers, market access is shifting in this immunology drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Read More

Topics: Specialty, Market Access, Branding & Marketing

Perspectives on Cigna-Express Scripts Deal

Posted by Matt Breese on Mar 13, 2018

Cigna Corp. on March 8 said it would buy Express Scripts Holding Co. in a $67 billion deal, a move that analysts say furthers the trend of payers and PBMs joining together in a single diversified entity. 

Cigna agreed to pay $48.75 in cash and 0.2434 shares of stock of the combined company for each Express Scripts share. Such a move would give the insurer control over the pharmacy space and a greater scale that helps cut costs, according to Jefferies analyst David Windley. 

Read More

Topics: Industry Trends, Branding & Marketing

Perspectives on Analytics Revolution in the Life Sciences Industry

Posted by Matt Breese on Mar 6, 2018

Looking ahead, life sciences companies should focus on making full use of analytics to translate insights to action, given that the industry is undergoing a transformative shift. 

Over the past few years, life sciences companies have been able to make more sophisticated and precise advances. Yet instead of changing decisions, their insights remain diagnostic. In 2018, leading brands should keep investing in infrastructure and rapid experimentation to generate prescriptive analytics. 

Read More

Topics: Industry Trends, Data & Analytics, Branding & Marketing

Trends That Matter for Promising Drugs in 2018

Posted by Matt Breese on Feb 22, 2018

FDA’s Center for Drug Evaluation and Research (CDER) approved 46 new drugs in 2017, more than doubling the number of novel medications approved in 2016.

Among the drugs that have been recently launched or will be launched soon, Dupixent, Ocrevus and Imfinizi top the most promising drugs in 2018, according to IgeaHub, a pharmaceutical club for industry influencers. 

Read More

Topics: Industry Trends, Product Release, Branding & Marketing

Perspectives on NASH Market

Posted by Matt Breese on Feb 20, 2018

Non-alcoholic Steatohepatitis (NASH), the severest form of non-alcoholic fatty liver disease (NAFLD), is expected to become the leading cause of liver transplantation by 2020 in the United States. This untapped market might become the next big market in the metabolic disorders segment.  
 
Currently, lifestyle modifications, such as diet and regular exercise, are the main initial therapeutic step. Bariatric surgery is considered the last option, which improves histology and causes massive weight loss. 
 
Read More

Topics: Industry Trends, Market Access, Branding & Marketing